BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Company Snapshot

Founded: 1885

Entity Type: Public

Employees: 53,565

Region: Americas

Revenue: $27,700.2 Millions

Revenue Year: 2023

Headquarter: Germany

Key Geographics: Americas, Europe, Asia, Australia, Africa

Corporate Address: Binger Strasse 173 55216 Ingelheim am Rhein Germany Tel. +49-6132-770 www.boehringer-ingelheim.com

Company Overview

Boehringer Ingelheim is a research-driven biopharmaceutical company with a presence in more than 170 countries. The company has collaborated with over 250 academic institutions and companies worldwide to address unmet medical needs. The company's long-term objective is to contribute to the pipeline analysis of products. Over 30% of pipeline products are based on external innovations.

Financial Highlights (FY 2023)

Net Revenue: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

BOEHRINGER INGELHEIM INTERNATIONAL GMBH In Reports

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

BCC Research Report: Dive into pharmaceutical drugs market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Neurology Market: A BCC Research Overview

BCC Research Report: Dive into neurology market Key products are analyzed to determine present and future market status, as well as forecasted growth from 2024 to 2029.

Global Market Opportunities and Competitive Landscape for CDMO

BCC Research Report: Dive into the contract development and manufacturing organization (CDMO) market analyzed to determine present and future market status, as well as forecasted growth from 2024 to 2029.

View All Reports

BOEHRINGER INGELHEIM INTERNATIONAL GMBH In News

百靈佳殷格翰任命 Alison Barker 女士為台灣動物保健事業處長 - Boehringer Ingelheim

Boehringer Ingelheim - May 19, 2025

「脈動台灣醫路前行」改善醫療環境的50個故事徵件中！ - Boehringer Ingelheim

Boehringer Ingelheim - Mar 25, 2025

健康好夥伴醫病互動衛教 - Boehringer Ingelheim

Boehringer Ingelheim - Feb 26, 2025

Simon Cho - Boehringer Ingelheim

Boehringer Ingelheim - Nov 05, 2024

Read All News

Company's Business Segments

Human Pharma : This segment focuses on cardiovascular and metabolic diseases, respiratory diseases, oncology, mental health, immunology, and retinal diseases.
Animal Health : The segment portfolio includes products for pets, horses, swine, ruminants, and poultry.

Applications/End User Industries

Healthcare
Pharmaceutical

Animal Health

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.